Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy is a research paper published in Antimicrobial Agents and Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: 1P30AI094189
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R61AI161809
Unitaid
Grant: 2020-38-LONGEVITY
NIAID NIH HHS
Grant: P30 AI094189
National Institutes of Health
Grant: 5R61AI161809-02
Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosis
National Institutes of Health
Grant: 3P30AI094189-13S3
The Johns Hopkins Center for AIDS Research (JHU CFAR)
Fields of Study
MeSH Terms
Keywords